HomeCompareBLPH vs YUM

BLPH vs YUM: Dividend Comparison 2026

BLPH yields 158.04% · YUM yields 1.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BLPH wins by $32.58M in total portfolio value
10 years
BLPH
BLPH
● Live price
158.04%
Share price
$0.01
Annual div
$0.02
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.68M
Annual income
$14,560,088.59
Full BLPH calculator →
YUM
YUM
● Live price
1.85%
Share price
$155.48
Annual div
$2.88
5Y div CAGR
51.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.0K
Annual income
$39,957.33
Full YUM calculator →

Portfolio growth — BLPH vs YUM

📍 BLPH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBLPHYUM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BLPH + YUM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BLPH pays
YUM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BLPH
Annual income on $10K today (after 15% tax)
$13,433.54/yr
After 10yr DRIP, annual income (after tax)
$12,376,075.30/yr
YUM
Annual income on $10K today (after 15% tax)
$157.45/yr
After 10yr DRIP, annual income (after tax)
$33,963.73/yr
At 15% tax rate, BLPH beats the other by $12,342,111.57/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BLPH + YUM for your $10,000?

BLPH: 50%YUM: 50%
100% YUM50/50100% BLPH
Portfolio after 10yr
$16.40M
Annual income
$7,300,022.96/yr
Blended yield
44.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on YUM right now

BLPH
Analyst Ratings
7
Buy
1
Hold
Consensus: Buy
Altman Z
-77.3
Piotroski
2/9
YUM
Analyst Ratings
18
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$173.15
+11.4% upside vs current
Range: $158.00 — $190.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BLPH buys
0
YUM buys
0
No recent congressional trades found for BLPH or YUM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBLPHYUM
Forward yield158.04%1.85%
Annual dividend / share$0.02$2.88
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.4%
Portfolio after 10y$32.68M$107.0K
Annual income after 10y$14,560,088.59$39,957.33
Total dividends collected$30.36M$80.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyHold

Year-by-year: BLPH vs YUM ($10,000, DRIP)

YearBLPH PortfolioBLPH Income/yrYUM PortfolioYUM Income/yrGap
1← crossover$26,504$15,804.17$10,980$280.44+$15.5KBLPH
2$67,507$39,147.31$12,185$435.72+$55.3KBLPH
3$165,418$93,186.16$13,722$684.14+$151.7KBLPH
4$390,402$213,404.75$15,773$1,090.14+$374.6KBLPH
5$888,436$470,705.22$18,650$1,773.02+$869.8KBLPH
6$1,951,729$1,001,103.05$22,921$2,966.37+$1.93MBLPH
7$4,143,713$2,055,363.02$29,685$5,158.69+$4.11MBLPH
8$8,512,033$4,078,259.67$41,216$9,453.02+$8.47MBLPH
9$16,937,387$7,829,511.79$62,672$18,571.31+$16.87MBLPH
10$32,683,093$14,560,088.59$107,016$39,957.33+$32.58MBLPH

BLPH vs YUM: Complete Analysis 2026

BLPHStock

Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated with fibrotic interstitial lung disease; which has completed Phase 2a clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary disease; and that has completed Phase 2 dose escalation stage for pulmonary hypertension associated with sarcoidosis, as well as for chronic thromboembolic pulmonary hypertension and pulmonary hypertension associated with pulmonary edema from high altitude sickness. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics, Inc. in January 2014. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey.

Full BLPH Calculator →

YUMConsumer Discretionary

YUM! Brands, Inc., together with its subsidiaries, develops, operates, and franchises quick service restaurants worldwide. It operates through four segments: the KFC Division, the Taco Bell Division, the Pizza Hut Division, and the Habit Burger Grill Division. The company operates restaurants under the KFC, Pizza Hut, Taco Bell, and The Habit Burger Grill brands, which specialize in chicken, pizza, made-to-order chargrilled burgers, sandwiches, Mexican-style food categories, and other food products. As of December 31, 2021, it had 26,934 KFC units; 18,381 Pizza Hut units; 7,791 Taco Bell units; and 318 The Habit Burger Grill units in approximately 157 countries and territories. The company was formerly known as TRICON Global Restaurants, Inc. and changed its name to YUM! Brands, Inc. in May 2002. YUM! Brands, Inc. was incorporated in 1997 and is headquartered in Louisville, Kentucky.

Full YUM Calculator →
📬

Get this BLPH vs YUM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BLPH vs SCHDBLPH vs JEPIBLPH vs OBLPH vs KOBLPH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.